Xspray Pharma AB (publ) (STO:XSPRAY)

Xspray Pharma AB Revenue

Xspray Pharma AB had revenue of 8.43M SEK in the quarter ending June 30, 2026, with 542.19% growth. This brings the company's revenue in the last twelve months to 12.19M, up 185.59% year-over-year. In the year 2025, Xspray Pharma AB had annual revenue of 6.43M with 206.87% growth.

• Revenue (ttm): 12.19M
• Revenue Growth: +185.59%
• P/S Ratio: 263.43
• Revenue / Employee: 102.75K
• Employees: 24
• Market Cap: 649.61M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.43M	4.34M	206.87%
Dec 31, 2024	2.10M	-29.67M	-93.40%
Dec 31, 2023	31.77M	29.59M	1,357.20%
Dec 31, 2022	2.18M	1.52M	232.32%
Dec 31, 2021	656.00K	-708.00K	-51.91%
Dec 31, 2020	1.36M	990.00K	264.71%
Dec 31, 2019	374.00K	11.00K	3.03%
Dec 31, 2018	363.00K	-793.00K	-68.60%
Dec 31, 2017	1.16M	-20.04M	-94.55%
Dec 31, 2016	21.19M	16.57M	358.36%
Dec 31, 2015	4.62M	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error